Myths About Success Rates Do they truly reflect quality of care

Similar documents
Fertility 101. About SCRC. A Primary Care Approach to Diagnosing and Treating Infertility. Definition of Infertility. Dr.

WHAT IS A PATIENT CARE ADVOCATE?

Hold On To Your Dreams

SpermComet DNA Test your results and what they mean

GYNEM PRICELIST 2018

Patient Price List. t: e: w:

Embryo Selection after IVF

Possibilities Plan. Access to the care you need.

Health Service System City & County of San Francisco

Do it Once, Do it Right

Fertility Policy. December Introduction

IVF while taking Estrace? 3,915 conversations on the web about experiences with taking Estrace before or after having a IVF.

Robin L. Poe-Zeigler, MD, FACOG. Dr. Robin

Problem Challenge Need. Solution Innovation Invention

Fertility assessment and assisted conception

Preimplantation Genetic Testing (PGT) Fresh and Frozen Embryos Process, Risk, and Consent

M Magdy EL-Sheikh FRCOG London, FRCS Glasgow Director ART unit Dr Soliman Fakeeh hospital Jeddah Saudi Arabia

INDICATIONS OF IVF/ICSI

Consent for Pre-Implantation Genetic Diagnosis (PGD), Embryo Biopsy and Disposition

Scientifically advanced. Personally accessible.

Fertility treatment in trends and figures

Increase your chance of IVF Success. PGT-A Preimplantation Genetic Testing for Aneuploidy (PGS 2.0)

Prepare your first visit to Sakthi Fertility

Iui Intrauterine Insemination

JAWDA Quarterly & Yearly Guidelines for Assisted Reproductive Technology Treatment (ART) Providers January 2019

CLINICAL RESULTS 2016

NICE fertility guidelines. Hemlata Thackare MPhil MSc MRCOG Deputy Medical Director London Women s Clinic

Biology of fertility control. Higher Human Biology

1 - Advanced clinical course for ART with Hands on

European IVF Monitoring (EIM) Year: 2012

Adoption and Foster Care

Approved January Waltham Forest CCG Fertility policy

Honorary Fellow of the Royal College of Obs. & Gyn. First Indian to receive FIGO s Distinguished Merit Award for Services towards women s health.

Optimize your success

Pre-Implantation Genetic Diagnosis. Bradley Kalinsky, MD Amanda Kalinsky, RN, BSN

PGS Embryo Screening

Reproductive Technology, Genetic Testing, and Gene Therapy

Clinical Policy Committee

Dr Manuela Toledo - Procedures in ART -

Society for Assisted Reproductive Technology and American Society for Reproductive Medicine

European IVF Monitoring (EIM) Year: 2013

IVF & SURROGACY STANDARD OPTION PRICING LIV FERTILITY CENTER, PUERTO VALLARATA, MEXICO AUTUMN 2015

Policy updated: November 2018 (approved by Haringey and Islington s Executive Management Team on 5 December 2018)

Note: This updated policy supersedes all previous fertility policies and reflects changes agreed by BHR CCGs governing bodies in June 2017.

Fertility treatment in trends and figures

A Stepwise Approach to Embryo Selection and Implantation Success

Planning for Parenthood After a Cancer Diagnosis

Getting Pregnant, Staying Pregnant & Post Pregnancy by Siobhán Boucher.

Pre-Implantation Genetic Diagnosis. Bradley Kalinsky, MD Amanda Kalinsky, RN, BSN

INSIDE IVF: HOW SCIENCE CARES FOR PATIENTS DR DEIRDRE ZANDER-FOX MONASH IVF GROUP HDA GRAND ROUND OCTOBER 31 ST 2018

Dr Guy Gudex. Gynaecologist and Fertility Specialist Repromed. 9:05-9:30 Advances in Assisted Reproduction What s New?

Preimplantation Genetic Testing Where are we going? Genomics Clinical Medicine Symposium Sept 29,2012 Jason Flanagan, MS,CGC

Number of oocytes and live births in IVF

Genetics Review and Reproductive Options in Kennedy Disease

How to advise the couple planning to conceive: Modifiable factors that may (or may not) impact fertility

OVERVIEW AND FACTS: CRYOPRESERVATION

Comprehensive chromosome screening and embryo biopsy: advantages and difficulties. Antonio Capalbo, PhD Italy

Preimplantation Genetic Diagnosis (PGD) in Western Australia

Building Your Family. at Northwestern Medicine Fertility and Reproductive Medicine

Comprehensive Chromosome Screening Is NextGen Likely to be the Final Best Platform and What are its Advantages and Quirks?

Influence ovarian stimulation on oocyte and embryo quality. Prof.Dr. Bart CJM Fauser

Brighton & Hove CCG PLS CONFERENCE Dr Carole Gilling-Smith Medical Director

Policy statement. Commissioning of Fertility treatments

2018 INFERTILITY TRENDS NATIONAL SURVEY

Infertility F REQUENTLY A SKED Q UESTIONS. Q: Is infertility a common problem?

Hold On To Your Dreams. Understanding IVF Process In Surrogacy The Basics

WELCOME TO NYU LANGONE FERTILITY CENTER

Understanding eggs, sperm and embryos. Marta Jansa Perez Wolfson Fertility Centre

INTRACYTOPLASMIC SPERM INJECTION

Preimplantation Genetic Diagnosis (PGD) single gene disorders. A patient guide

Consultations and Assessment Fertility Specialist consultation 180 Ultrasound scan of uterus and ovaries 100 AMH measurement 80 Semen analysis 100

Neurofibromatosis 2: Genetics and Prenatal Diagnosis

Clinical Policy Committee

reproductive M E D I C I N E

Erez Baron Families Through Surrogacy October 2017

COMMISSIONING POLICY. Tertiary treatment for assisted conception services

ASSISTED REPRODUCTIVE TECHNOLOGIES (ART)

Understanding IVF Processes in Surrogacy

IVF AND PREIMPLANTATION GENETIC TESTING FOR ANEUPLOIDY (PGT-A) WHAT THE COMMUNITY PHYSICIAN NEEDS TO KNOW

Therapeutic Sperm Banking

INFERTILITY SERVICES

Family Building Through Use of DONATED EMBRYOS. Robin L. Poe-Zeigler, MD, FACOG

Infertility in Women over 35. Alison Jacoby, MD Dept. of Ob/Gyn UCSF

We can give you the very best chance of having a baby.

IRB USE ONLY Approval Date: September 10, 2013 Expiration Date: September 10, 2014

Welcome. Fertility treatment can be complicated. What s included. Your fertility treatment journey begins here. Fertility treatment basics 2

Treating Infertility

UNDERSTANDING THE GENETIC HEALTH OF EMBRYOS

Newlife Fertility Price List

Family Building for Transgender Men and Women

Medical Affairs Policy

Newlife Fertility Price List

New perspectives on embryo biopsy, not how, but when and why PGS

Commissioning Policy For In Vitro Fertilisation (IVF) / Intracytoplasmic Sperm Injection (ICSI) within Tertiary Infertility Services

Cycle Plan Page1 CYCLE PLAN TYPE CYCLE TYPE: Initial Plan Updated Plan Management Team Review Monitoring Review

FACT SHEET. Failure of Ovulation Blocked or Damaged Fallopian TubesHostile Cervical Mucus Endometriosis Fibroids

Application of OMICS technologies on Gamete and Embryo Selection

Fertility treatment and referral criteria for tertiary level assisted conception

Trends in Egg Donation. Vitaly A. Kushnir MD Center for Human Reproduction

Transcription:

Myths About Success Rates Do they truly reflect quality of care Barry Behr PhD., HCLD Professor and IVF Laboratory Director Division of Reproductive Endocrinology and Infertility Dept OB/GYN Stanford University

Disclosures Founder of Auxogyn (Progyny) Founder of Ivigen

Dr Look Good vs. Dr Treat All Is this what it is all about?

What does success mean? Depends on your perspective

Good fert: Perfect 2PN!

Good Looking Day 3 Embryos

Hatching Blastocysts (on time)

Ultimate (short term) Goal Achieve a healthy singleton pregnancy Transfer fewer embryos (1 or 2)

IVF lab cant change the raw materials Have to consider the front end of the process The patient never dies in the OR Always the labs fault

The Perspective The Patient s The IVF Program The Agency What about the child

Technology High vs low complex The ICSI phone call Does achieving a positive outcome with a lower tech more successful than overkill (ie 100% ICSI or PGS) Now adding TLM, PGS, freeze all, ERA

Killing a fly with a sledgehammer Is there such a thing as overkill Ie is it better or is one more successful if you do more with less? How do we interpret success when unnecessary technology is applied?

Success vs Success Rate

Pregnancy Rate Per cycle start Per egg retrieval Per embryo transfer Confounders: Freeze all/pgs Banking/batching Cycle conversions (to/from IUI)

Implantation Rate Sac Heartbeat Location: Uterus vs Ectopic

Outcome Reporting SART - disclaimer CDC Non Reporters Consequences (lack thereof) of non- compliance (fraud)

What is the background (natural) success rate?

Approximate pregnancy rates per At peak fertility (20s): 20-25% Mid 30s: 15% Age 40: 5% Mid 40s: 1% cycle in fertile couples The most fertile couples will become pregnant quickly, rates drop the longer a couple has been trying

Normal Reproductive Process

Pregnancy rates for sub-fertile couples with no treatment Overall 2-3%, lower for older couples Depends on Reason for lack of successful pregnancy Age Length of attempting (in general, lower rate if longer)

Why do people consider In Vitro Fertilization (IVF)? Simpler treatment is not successful The reason for infertility cannot be treated using a simpler treatment (e.g. tubal disease, very poor sperm quality) A man and/or woman carriers serious genetic disease that they wish to avoid passing on to children Time to pregnancy

No Risk Adjusters for IVF Reporting (other than age) Other areas of Medicine use modifiers

Does success rate depend on Diagnosis? Problem with combined male and female diagnosis in SART

Which Diagnosis has the most influence on success rate?

SART not for comparing programs

Why?

Effects of PGD/S on outcomes Sex selection Mutation avoidance Real aneuploidy risk (age)

Does Euploidy level the playing field?(across the ages) So again, how to interpret success: is it only the pregnancy rate?

Embryo biopsy techniques Move from Day 3 to Day 5 biopsy Single cell genetics FISH Snps Arrays Sequencing Cryopreservation Higher implantation rates Advances in PGD

What a difference a decade makes 2000* 2015* Implantation Rate (live birth per embryo transferred) Number of embryos transferred 10-20% 30-50+% 2-4 1-2 Error rates 2-11% 1-2% Miscarriage rate 20+% 5-10%

Conclusions regarding statistics Statistics provide an estimate, but outcome for individuals can t be precisely predicted based on statistics for a group We want to provide as accurate an estimate as possible to help patients make informed decisions At Stanford, for example, we have no cut-offs for treatment based on success, regardless of what the statistics may predict

Conclusions IVF Reporting is unique for Medicine National Data Summaries show trends Patients are the primary dictators of success PGS utility has and impact Preg per ER vs ET vs Total cycle potential